Himanshu Pharmaceuticals Private Limited
About Himanshu Pharmaceuticals Private Limited
Data last updated:
Himanshu Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 July 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85110KA1990PTC011072. Its GSTIN is 29AAACH9822J1Z8 (Karnataka).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹19.87 Lakh. It is led by directors including Satish Kumar Parmar (Whole-Time Director) and Krishi Parmar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹27.58 Lakh, a decline of 76% compared to the previous year. For the same year it recorded a net profit of ₹8.79 Lakh (net margin 31.9%) and EBITDA of ₹16.16 Lakh (EBITDA margin 58.6%). Revenue has declined at a compounded annual rate (CAGR) of 41% over three years and 25% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Himanshu Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo 6/5 2nd Floor Sarda Heights, 5th Cross Mysore Road, Bangalore, Karnataka, India – 560026
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Himanshu Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Himanshu Pharmaceuticals Private Limited
FY 2025 filings availableHimanshu Pharmaceuticals Private Limited reported revenue of ₹27.58 Lakh (down 76% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 25% over five years, including a 76% fall in the latest year. EBITDA fell 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.79 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 58.6% | ||||
| Net Profit Margin | 31.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Himanshu Pharmaceuticals Private Limited, buy the company report.
Board of directors of Himanshu Pharmaceuticals Private Limited
Himanshu Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishi Parmar | Director | 04 May 2024 | 2 Years 6 Months | Current |
| Kajal Kiran Parmar | Director | 04 May 2024 | 2 Years 6 Months | Current |
| Satish Kumar Parmar | Whole-Time Director | 14 Oct 1998 | 28 Years 0 Months | Current |
Peer comparison
Himanshu Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bluedrop Retails Private Limited | ₹27.6 Lakh (FY 2022) | 198.0% | Anand, Gujarat, India | |||
| Suniris Enterprises OPC Private Limited | ₹27.6 Lakh (FY 2019) | 1009.0% | Bhatinda, Punjab, India | |||
| Himanshu Pharmaceuticals Private Limitedthis company | ₹27.58 Lakh (FY 2024) | ₹8.79 Lakh | 31.9% | -76.0% | Bangalore, Karnataka, India | |
| Rawat Eye Care Private Limited | ₹27.58 Lakh (FY 2024) | 67.0% | Jaipur, Rajasthan, India | |||
| Eshar Healthcare Private Limited | ₹27.48 Lakh (FY 2020) | 8964.0% | Uttar Pardesh, Uttar Pradesh, India | |||
| Skin Habits Private Limited | ₹27.47 Lakh (FY 2024) | 234.0% | Chandigarh, India |
To see the full peer comparison of Himanshu Pharmaceuticals Private Limited, buy the company report.
Auditor
Himanshu Pharmaceuticals Private Limited is audited by PRITHVI RAJ V MEHTA for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRITHVI RAJ V MEHTA | FY 2022 | 020609 |
Shareholding
The shareholding of Himanshu Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Himanshu Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Himanshu Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Himanshu Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Himanshu Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
Himanshu Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAACH9822J1Z8 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Himanshu Pharmaceuticals Private Limited, buy the company report.
Recent activity
Himanshu Pharmaceuticals Private Limited has 6 board changes on record since 1998: 3 appointments and 3 cessations. The latest: Chandulal Parmar ceased to be Whole-Time Director on 27 May 2024.
Frequently asked questions
Himanshu Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 July 1990 (36+ years old) and is registered under CIN U85110KA1990PTC011072.
Himanshu Pharmaceuticals has 3 current directors:
- Satish Kumar Parmar - Whole-Time Director
- Krishi Parmar - Director
- Kajal Kiran Parmar - Director
The latest financial statements of Himanshu Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Himanshu Pharmaceuticals is 29AAACH9822J1Z8, registered in Karnataka.
The CIN (Corporate Identification Number) of Himanshu Pharmaceuticals is U85110KA1990PTC011072. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Himanshu Pharmaceuticals was incorporated on 17 July 1990, making it 36+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Himanshu Pharmaceuticals by revenue are Bluedrop Retails Private Limited, Suniris Enterprises OPC Private Limited, Rawat Eye Care Private Limited, Eshar Healthcare Private Limited, Skin Habits Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Chandulal Parmar ceased to be Whole-Time Director on 27 May 2024. Dinesh Kumar Parmar ceased to be Director on 27 May 2024. Praveen Kumar Parmar ceased to be Managing Director on 27 May 2024. Himanshu Pharmaceuticals has 6 board changes on record in total.
The registered office of Himanshu Pharmaceuticals is at No 65 2nd Floor Sarda Heights, 5th Cross Mysore Road, Bangalore, Karnataka, India – 560026.
Himanshu Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Himanshu Pharmaceuticals is compliant as of 26 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
